Keyphrases
Age at Diagnosis
16%
Allogeneic
16%
Conventional Chemotherapy
33%
Cord Blood
16%
Donor Source
16%
Hematopoietic Stem Cell Transplantation
100%
Hematopoietic Stem Cells
16%
Hematopoietic System
16%
Immunomodulatory Effect
16%
Improved Outcomes
100%
Japan
100%
Langerhans Cell Histiocytosis
100%
Liver
16%
Lung
16%
Myeloablative Regimen
16%
No Evidence of Disease
33%
Organ Involvement
50%
Overall Survival Rate
33%
Poor Outcome
16%
Reduced-intensity Conditioning
16%
Risk Organ
50%
Spleen
16%
Stem Cells
83%
Tion
100%
Working Diagnosis
33%
Immunology and Microbiology
Conditioning
16%
Hematopoietic Stem Cell
16%
Hematopoietic Stem Cell Transplantation
100%
Hematopoietic System
16%
Langerhans Cell
100%
Overall Survival
33%
Stem Cell
83%
Survival Rate
33%